Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1241-1249, 2005. First published May 19, 2005; 10.1373/clinchem.2004.046565
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
clinchem.2004.046565v1
51/7/1241    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ollert, M.
Right arrow Articles by Ring, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ollert, M.
Right arrow Articles by Ring, J.
Related Collections
Right arrow Clinical Immunology
(Clinical Chemistry. 2005;51:1241-1249.)
© 2005 American Association for Clinical Chemistry, Inc.

Clinical Immunology

Allergen-Specific IgE Measured by a Continuous Random-Access Immunoanalyzer: Interassay Comparison and Agreement with Skin Testing

Markus Ollert1,2,a, Stephanie Weissenbacher1, Jürgen Rakoski1 and Johannes Ring1,3

1 Department of Dermatology and Allergy, Biederstein, 2 Clinical Research Division of Molecular and Clinical Allergotoxicology, and 3 Division of Environmental Dermatology and Allergy GSF/TUM, Technical University of Munich, Munich, Germany.

aAddress correspondence to this author at: Department of Dermatology and Allergy, Biederstein, Technische Universität München (TUM), Biedersteiner Strasse 29, D-80802 Munich, Germany. Fax 49-89-4140-3552; e-mail ollert{at}lrz.tum.de.

Background: Our aims were to evaluate the performance of a fully automated system for measuring circulating allergen-specific IgE (sIgE) against an established in vitro assay and to assess the system’s diagnostic accuracy against objective clinical criteria for identifying sensitization to specific allergens.

Methods: Using both the IMMULITE® 2000 Allergy system (IML) and an assay based on the widely used ImmunoCAP® technology (CAP), we measured sIgE in serum samples from 169 persons with suspected allergies to airborne or insect venom allergens. Skin testing outcome served as the clinical comparison method.

Results: Interassay classification agreement between the IML and CAP, relative to the usual allergen-specific IgE cutoff of 0.35 kIU/L, ranged from 76% (yellow jacket venom) to 95% (orchard grass); agreement was 88.3% for all 9 allergens combined (766 results). The 90 discordant results, when resolved by skin testing, showed better agreement with the IML (72%) than with the CAP (28%). Compared with skin testing, for each of the 9 allergens studied, the area under the ROC curve was at least as large for the IML as for the CAP, reflecting in part the more extensive working range of the IML (0.10–100 kIU/L vs 0.35–100 kIU/L for CAP).

Conclusion: Laboratory testing for sIgE can be performed on a fully automated, random-access system with an extended working range and with diagnostic accuracy for representative allergens equivalent to or better than that of the semiautomated CAP technology.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.